期刊文献+

肾小球滤过率联合尿微量白蛋白与肌酐比值诊断糖尿病肾病的临床意义 被引量:19

Clinical significance of glomerular filtration rate combined with urinary microalbumin and urinary creatinine ratio in diagnosis of diabetic nephropathy
下载PDF
导出
摘要 目的:探讨2型糖尿病病人采用改良的中国公式计算肾小球率过滤(c-a GFR)联合尿微量白蛋白与尿肌酐比值(ACR)在诊断糖尿病肾病不同阶段中的临床意义,并做c-a GFR和ACR的相关性分析。方法:根据ACR不同阶段分成4组,A组(正常对照组),B组(糖尿病正常白蛋白尿组ACR〈30mg/g),C组(糖尿病肾病微量白蛋白尿组ACR30~300mg/g),D组(糖尿病肾病大量蛋白尿组ACR〉300mg/g);应用改良中国MDRD公式c-a GFR(m L/min·1.73m^2)=175×[Hit Pcr]-1.234×年龄-0.179×[女性×0.79]计算GFR,(即c-a GFR,m L/min·1.73m^2)。双变量相关性分析采用Pearson相关分析。结果:与正常对照组相比糖尿病正常白蛋白尿组c-a GFR无明显变化(P〉0.05),糖尿病肾病微量白蛋白尿组与正常对照组相比c-a GFR降低,有显著变化(P〈0.05),糖尿病肾病大量蛋白尿组与正常对照组相比c-a GFR降低,有显著变化(P〈0.05),糖尿病肾病大量白蛋白尿组与糖尿病肾病微量蛋白尿组相比c-a GFR降低,有显著变化(P〈0.05)。与正常对照组相比糖尿病正常白蛋白尿组ACR无明显变化(P〉0.05),糖尿病肾病微量白蛋白尿组与正常对照组相比ACR增高,有显著变化(P〈0.05),糖尿病肾病大量蛋白尿组与正常对照组相比ACR增高,有显著变化(P〈0.05),糖尿病肾病大量白蛋白尿组与糖尿病肾病微量蛋白尿组相比ACR增高,有显著变化(P〈0.05)。c-a GFR随着ACR的增加呈下降趋势,Pearson分析显示二者具有显著负相关性。结论:c-a GFR及ACR可以做为糖尿病肾病诊断的重要监测指标;二者联合检测可以更准确的评估糖尿病患者肾脏功能的情况,对调整糖尿病患者经肾脏代谢的药物剂量及药物的选择都有极为重要的临床指导价值。 Objective: For type 2 diabetic patients,to study the clinical significance of modified Chinese formula to calculate the rate of Glomerular filtration( c- a GFR) combined urinary microalbumin and urinary creatinine ratio( ACR) in the diagnosis of different stages of diabetic nephropathy; and to analyze the correlation between c- a GFR and ACR. Methods: 4 groups were divided according to the different stages of ACR,Group A( normal control group),Group B( diabetes normal albuminuria group ACR 30 mg /g),Group C( diabetic nephropathy microalbuminuria group ACR30 ~ 300 mg / g),Group D( proteinuria of diabetic nephropathy group ACR 300 mg / g). Modified Chinese c- a GFR MDRD formula( m L / min·1. 73m^2) = 175 ×[Hit Pcr]- 1. 234 × age- 0. 79 ×[female × 0. 79] was used to calculate GFR,( that is,c- a GFR,m L / min·1. 73m^2). Pearson correlation was used to analyze Bivariate correlation. Results: Compared with normal control group,c- a GFR in group B did not change significantly( P〉0. 05). C- a GFR in Group C was lower than that in group A significantly( P 〈0. 05). C- a GFR in Group D reduced significantly compared with control group( P 〈0. 05). c- a GFR in Goup D was lower than that in Croup C significantly( P 〈0. 05). There was no significant change of ACR in Group B compared with control group( P 〉0. 05). ACR increased significantly in Group C compared with control group( P 〈0. 05). ACR increased significantly in group D compared with control group( P 〈0. 05). ACR in Group D increased significantly compared with group C( P 〈0. 05). c- a GFR was on downward trend alongside the increase of ACR. Pearson analysis showed that there existed significant negative correlation between the two.Conclusions: c- a GFR and ACR can be used as indicators for monitoring diabetic nephropath. Combined detection can much more accurately assess renal function in patients with diabetes,which has important clinical valu to adjust Diabetic Renal metabolism of drug dosages and drug choices.
出处 《黑龙江医药科学》 2015年第2期93-95,共3页 Heilongjiang Medicine and Pharmacy
关键词 2型糖尿病 糖尿病肾病 肾小球滤过滤 尿微量白蛋白与尿肌酐比值 type 2 diabetes mellitus diabetic nephropathy glomerular filtration urinary microalbumin and urinary creatinine ratio
  • 相关文献

参考文献12

  • 1Fioretyo P,Mauer M. Histopathology of diabetic nephmpatlly[ J]. Se- rain Nephrol,2007 ,27 :195.
  • 2Atkius RC, PoDdnghome KR, Briganti EM, et al. Prevalence of al- buminuria in Australia: The Ausdiab kidney study t J 1- I~idney IntSupp1,2004,12 (92) :22 - 41.
  • 3Price CP, Newall RQ, Boyd JC. Use of protein: creatinine ratiomeasurements on random urine samples for predication of significant- proteinuria: a systematic review [J]. Clin them, 2005, 51: 1577- 1586.
  • 4Andrew S, Levey MD, Josef Coresh PD, et al. National Kidney Foundation. K/DOQI for chronic kidney disease ; evaluation classifi- cation, and stratification [ J ]. Am J Kidney Dis, 2002,39 ( 1 ) : 1 - 266.
  • 5Ng W, Lui KF, Thai A. Evaluation of a rapid screening test for mi- croalbuminuria with a spot meusarement of uriaealbumin - creatinine ratio [ J ]. Diabet Med, 2000,17 ( 1 ) :7 - 10.
  • 6Reportof a WHO consultation. Definition, diagnosis and classification of diabetes mellitus and its complications Part 1 [ R]. Geneva: World Health Organization, 1999.
  • 7魏守建.金水宝胶囊联合贝那普利治疗早期2型糖尿病肾病疗效观察[J].黑龙江医药科学,2010,33(1):50-50. 被引量:7
  • 8袁婧玮,袁静波.胱抑素C、嗜铬粒蛋白A与慢性充血性心力衰竭的实验研究[J].黑龙江医药科学,2012,35(6):50-51. 被引量:5
  • 9West KM, Erdereich LJ, Stober JA. A detailed study of risk fac - tots for retinopathy and nephropathy in diabetes [ J ] : Diabetes, 1980,29 : 501.
  • 10Shichiri M, Kishikawa H, Ohkubo Y, et al. Long - term results of the Kumamo to Study on optimal diabetes control in type2dia - betic pa- tients [ J J. Diabetes Care,2000,23:21.

二级参考文献12

  • 1龚伟,黎磊石,陈丹,孙骅,贾忠辉,曾彩虹,刘志红.百令(冬虫夏草)对糖尿病大鼠转化生长因子β及其受体表达的影响[J].肾脏病与透析肾移植杂志,2006,15(4):329-339. 被引量:36
  • 2White KE. research into the glomerular podocyte-is it relevant to diabetic nephropathy[J]. Diabet Med, 2006,23 : 715-719.
  • 3Makino H, Nakamura Y, Wada J. Remission and regression of diabetic nephropathy[J]. Hypertens Res, 2003,26 : 515-519.
  • 4Tag lieriN,koenig W,Kaski JC,et al. Cystatin c and cardiovascular rish[J]. Clinical Chemistry, 2009,55(11) :1932-1943.
  • 5Patel PC, Ayers CR, Murphy SA,et al. Association of cystatin C with Left ventrieular structure and Association by contrast t the Dallas Heart Study[J]. Cire Heart Fail,2009,2(2):98-104.
  • 6Moran A, Katz R,Smith NL, et al. Cystatin C concentration as a Predictor of systolic and diastolic heart failure [J]. J card Fail, 2008,14 (1) : 19-26.
  • 7Nieeoli G,Conte M, DellaBona R, et al. Cystatin C is associated with an increased coronary atherosclerotie burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate [J ]. Atherosclerosis, 2008, 198 ( 2 ) : 373- 380.
  • 8Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovascular risk [J]. Clin Chen, 2009,55(11):1932-1943.
  • 9赵秀芳,司一民.老年高血压病血小板聚集率和胱抑素C关系的研究[J].心血管康复医学杂志,2010,19(2):136-137. 被引量:31
  • 10贾峥嵘.卡托普利联用冬虫夏草制剂对Ⅱ型糖尿病肾病早期微白蛋白尿的影响[J].中国中西医结合急救杂志,1999,6(12):566-567. 被引量:15

共引文献9

同被引文献151

引证文献19

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部